Status:
UNKNOWN
The Impact Evaluation of the COVID-19 Prevention on Risk Factors of HIV and Sexually Transmitted Comorbidity
Lead Sponsor:
National Taiwan University
Collaborating Sponsors:
Ministry of Science and Technology, Taiwan
Conditions:
COVID-19 Pandemics
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Brief Summary
This is a cross-sectional research. The Protection Motivation Theory (PMT) was applied as theoretical framework to analyze correlation of prevention knowledge, prevention intentions and anxiety, and p...
Detailed Description
The prevention strategies can effectively block the spread of Coronavirus disease (Coronavirus disease 19; COVID-19), and at the same time may indirectly reduce or increase the risk behaviors and fact...
Eligibility Criteria
Inclusion
- Inclusion Criteria for HIV/AIDS participants:
- Participants who diagnosed with HIV/AIDS.
- Age over 18 years old.
- Participants who can read and communicate.
- Exclusion Criteria for HIV/AIDS participants:
- 1\. Participants who can't read and communicate.
- Inclusion Criteria for HIV high risk group:
- Participants who have experienced unsafe sex, regardless of their gender orientation, such as those who describe themselves as men who have sex with men (MSM), heterosexuals, transgender, sex workers, etc.
- Injecting Drug User(IDU)
- Age over 18 years old.
- Participants who can read and communicate.
- Exclusion Criteria for HIV high risk group:
- 1\. Participants who can't read and communicate.
Exclusion
Key Trial Info
Start Date :
January 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2023
Estimated Enrollment :
2200 Patients enrolled
Trial Details
Trial ID
NCT05188456
Start Date
January 13 2022
End Date
July 31 2023
Last Update
April 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Nursing of National Taiwan University
Taipei, Taiwan, 100